abstract |
The present invention relates to optically pure compounds of 2-phenyl-1,2-ethanediol single carbamate and 2-phenyl-1,2-ethanediol dicarbamate substituted with halogen atoms, which compounds treat central nervous system disease. In particular, it has been found to be effective as an anticonvulsant or an antiepileptic agent. |